MEDNAX, Inc. (NYSE:MD) is scheduled to speak at the 28th Annual JP Morgan Healthcare conference on Wednesday, January 13. The company will be represented by its Chief Executive Officer Roger Medel, M.D. Dr. Medel will begin its presentation at 7:30 am PT that morning. Interested parties may listen to a webcast of the presentation at www.mednax.com. For more information, contact Bob Kneeley (Investor Relations) at 954.384.0175 x-5300.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Mednax, Inc., formerly Pediatrix Medical Group, Inc. (Pediatrix), is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialty, and anesthesia care. During the year ended December 31, 2008, the Company's network was composed of approximately 1,274 affiliated physicians, including 844 neonatal physician specialists who provide clinical care in 32 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company has 143 affiliated physicians who provide maternal-fetal medical care to expectant mothers experiencing complicated pregnancies in many areas where its affiliated neonatal physicians practice. Its network includes other pediatric subspecialists, including 89 physicians providing pediatric cardiology care, 37 physicians providing pediatric intensive care and 20 physicians providing hospital-based pediatric care.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
